

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Rap protein signal transduction (GO:0032486) | 4.34785016 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 4.33621903 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.19381203 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.09482189 |
| 5 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.98426394 |
| 6 | neuronal action potential propagation (GO:0019227) | 3.98147092 |
| 7 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.92072870 |
| 8 | synaptic vesicle maturation (GO:0016188) | 3.88334792 |
| 9 | negative regulation of complement activation (GO:0045916) | 3.85863328 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 3.75426746 |
| 11 | glutamate secretion (GO:0014047) | 3.74914311 |
| 12 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.73720092 |
| 13 | vocalization behavior (GO:0071625) | 3.70742917 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.63928482 |
| 15 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.54705429 |
| 16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.54388143 |
| 17 | protein localization to synapse (GO:0035418) | 3.53137396 |
| 18 | locomotory exploration behavior (GO:0035641) | 3.51136548 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 3.45538918 |
| 20 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.41743233 |
| 21 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.41491977 |
| 22 | proline transport (GO:0015824) | 3.38057205 |
| 23 | negative regulation of protein activation cascade (GO:2000258) | 3.36779883 |
| 24 | neurotransmitter secretion (GO:0007269) | 3.24156985 |
| 25 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.23094035 |
| 26 | negative regulation of humoral immune response (GO:0002921) | 3.19939331 |
| 27 | glutamate receptor signaling pathway (GO:0007215) | 3.14405832 |
| 28 | protein K11-linked deubiquitination (GO:0035871) | 3.13831569 |
| 29 | regulation of germinal center formation (GO:0002634) | 3.10143030 |
| 30 | exploration behavior (GO:0035640) | 3.08127416 |
| 31 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.07946172 |
| 32 | regulation of vesicle fusion (GO:0031338) | 3.07220800 |
| 33 | transepithelial transport (GO:0070633) | 3.03107632 |
| 34 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.00828995 |
| 35 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.00609413 |
| 36 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.94101128 |
| 37 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.93308876 |
| 38 | neuron-neuron synaptic transmission (GO:0007270) | 2.90272586 |
| 39 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.89995278 |
| 40 | synaptic transmission, glutamatergic (GO:0035249) | 2.89616417 |
| 41 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.88297194 |
| 42 | cellular potassium ion homeostasis (GO:0030007) | 2.85986312 |
| 43 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.84559995 |
| 44 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.84559995 |
| 45 | membrane depolarization during action potential (GO:0086010) | 2.83089213 |
| 46 | cellular response to ethanol (GO:0071361) | 2.80092454 |
| 47 | long-term memory (GO:0007616) | 2.79936019 |
| 48 | regulation of postsynaptic membrane potential (GO:0060078) | 2.79718849 |
| 49 | synaptic vesicle endocytosis (GO:0048488) | 2.78967356 |
| 50 | presynaptic membrane assembly (GO:0097105) | 2.77508513 |
| 51 | cellular response to exogenous dsRNA (GO:0071360) | 2.75208021 |
| 52 | neurotransmitter transport (GO:0006836) | 2.74111190 |
| 53 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.74074278 |
| 54 | regulation of neurotransmitter secretion (GO:0046928) | 2.72363011 |
| 55 | negative regulation of dendrite development (GO:2000171) | 2.71687635 |
| 56 | response to pain (GO:0048265) | 2.70376908 |
| 57 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.69751527 |
| 58 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.69028970 |
| 59 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.68787886 |
| 60 | postsynaptic membrane organization (GO:0001941) | 2.68079079 |
| 61 | membrane depolarization (GO:0051899) | 2.67507232 |
| 62 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.64710960 |
| 63 | regulation of memory T cell differentiation (GO:0043380) | 2.64252265 |
| 64 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.64141085 |
| 65 | negative regulation of cell killing (GO:0031342) | 2.62425831 |
| 66 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.62425831 |
| 67 | positive regulation of membrane potential (GO:0045838) | 2.60936268 |
| 68 | activation of protein kinase A activity (GO:0034199) | 2.60575473 |
| 69 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.59712813 |
| 70 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.58596407 |
| 71 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.58139229 |
| 72 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.58045660 |
| 73 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.57820108 |
| 74 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.57820108 |
| 75 | negative regulation of heart rate (GO:0010459) | 2.57488724 |
| 76 | regulation of protein kinase A signaling (GO:0010738) | 2.57404095 |
| 77 | regulation of synapse structural plasticity (GO:0051823) | 2.56593163 |
| 78 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.56131297 |
| 79 | neuronal action potential (GO:0019228) | 2.55637337 |
| 80 | transmission of nerve impulse (GO:0019226) | 2.55104783 |
| 81 | cellular biogenic amine catabolic process (GO:0042402) | 2.55054578 |
| 82 | amine catabolic process (GO:0009310) | 2.55054578 |
| 83 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.54266814 |
| 84 | regulation of T-helper cell differentiation (GO:0045622) | 2.53589801 |
| 85 | neuron recognition (GO:0008038) | 2.52581706 |
| 86 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.52577604 |
| 87 | vesicle transport along microtubule (GO:0047496) | 2.52555776 |
| 88 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.52547878 |
| 89 | synapse assembly (GO:0007416) | 2.52541533 |
| 90 | peripheral nervous system neuron development (GO:0048935) | 2.52483385 |
| 91 | natural killer cell activation involved in immune response (GO:0002323) | 2.51762173 |
| 92 | inositol phosphate-mediated signaling (GO:0048016) | 2.51731351 |
| 93 | gamma-aminobutyric acid transport (GO:0015812) | 2.51505665 |
| 94 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.51399479 |
| 95 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.50997280 |
| 96 | behavioral response to ethanol (GO:0048149) | 2.48735704 |
| 97 | synaptic vesicle transport (GO:0048489) | 2.48000114 |
| 98 | establishment of synaptic vesicle localization (GO:0097480) | 2.48000114 |
| 99 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.47400793 |
| 100 | presynaptic membrane organization (GO:0097090) | 2.47108799 |
| 101 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.47018555 |
| 102 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.45979737 |
| 103 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.45645198 |
| 104 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.45634834 |
| 105 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.45043686 |
| 106 | regulation of regulatory T cell differentiation (GO:0045589) | 2.44934558 |
| 107 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.44893832 |
| 108 | immunoglobulin mediated immune response (GO:0016064) | 2.43594537 |
| 109 | long-term synaptic potentiation (GO:0060291) | 2.43539383 |
| 110 | regulation of axon regeneration (GO:0048679) | 2.43380389 |
| 111 | regulation of neuron projection regeneration (GO:0070570) | 2.43380389 |
| 112 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.42712779 |
| 113 | synaptic transmission (GO:0007268) | 2.42489843 |
| 114 | regulation of activation of Janus kinase activity (GO:0010533) | 2.41625046 |
| 115 | regulation of cell communication by electrical coupling (GO:0010649) | 2.41499126 |
| 116 | behavioral response to pain (GO:0048266) | 2.41448703 |
| 117 | regulation of synaptic plasticity (GO:0048167) | 2.41096865 |
| 118 | regulation of neurotransmitter transport (GO:0051588) | 2.41029390 |
| 119 | response to interferon-beta (GO:0035456) | 2.40979595 |
| 120 | regulation of neurotransmitter levels (GO:0001505) | 2.40344243 |
| 121 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.40074037 |
| 122 | establishment of endothelial barrier (GO:0061028) | 2.40022708 |
| 123 | detection of calcium ion (GO:0005513) | 2.39561458 |
| 124 | innervation (GO:0060384) | 2.39532569 |
| 125 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.39415773 |
| 126 | transferrin transport (GO:0033572) | 2.39414492 |
| 127 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.38956302 |
| 128 | cell migration in hindbrain (GO:0021535) | 2.38692129 |
| 129 | negative regulation of interleukin-17 production (GO:0032700) | 2.38339989 |
| 130 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.38243289 |
| 131 | positive regulation of action potential (GO:0045760) | 2.37919747 |
| 132 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.37372276 |
| 133 | calcium ion-dependent exocytosis (GO:0017156) | 2.37223998 |
| 134 | histamine transport (GO:0051608) | 2.36968044 |
| 135 | sensory perception of pain (GO:0019233) | 2.36191649 |
| 136 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.33370353 |
| 137 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.32916702 |
| 138 | production of molecular mediator of immune response (GO:0002440) | 2.32669250 |
| 139 | iron ion import (GO:0097286) | 2.32585307 |
| 140 | cellular response to interleukin-15 (GO:0071350) | 2.32026036 |
| 141 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.31280170 |
| 142 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.29027006 |
| 143 | T-helper cell differentiation (GO:0042093) | 2.29027006 |
| 144 | positive regulation of defense response to virus by host (GO:0002230) | 2.27917412 |
| 145 | histamine secretion (GO:0001821) | 2.27591791 |
| 146 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.27243343 |
| 147 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.26870881 |
| 148 | regulation of interferon-alpha production (GO:0032647) | 2.26803662 |
| 149 | regulation of T-helper 1 type immune response (GO:0002825) | 2.26747947 |
| 150 | response to type I interferon (GO:0034340) | 2.26421502 |
| 151 | regulation of cellular extravasation (GO:0002691) | 2.25745946 |
| 152 | ER overload response (GO:0006983) | 2.24343726 |
| 153 | cytokine biosynthetic process (GO:0042089) | 2.24224391 |
| 154 | type I interferon signaling pathway (GO:0060337) | 2.23810366 |
| 155 | cellular response to type I interferon (GO:0071357) | 2.23810366 |
| 156 | positive regulation of protein autophosphorylation (GO:0031954) | 2.23682861 |
| 157 | response to interleukin-15 (GO:0070672) | 2.23513408 |
| 158 | positive regulation of macrophage differentiation (GO:0045651) | 2.22014823 |
| 159 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.21981905 |
| 160 | positive regulation of interferon-alpha production (GO:0032727) | 2.21584195 |
| 161 | sleep (GO:0030431) | 2.21338491 |
| 162 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.20835547 |
| 163 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.20675041 |
| 164 | lymph node development (GO:0048535) | 2.20664956 |
| 165 | negative regulation of bone resorption (GO:0045779) | 2.20405965 |
| 166 | negative regulation of cytokine secretion (GO:0050710) | 2.17832461 |
| 167 | positive regulation of interleukin-12 production (GO:0032735) | 2.16958742 |
| 168 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.16021993 |
| 169 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.15191542 |
| 170 | keratinocyte development (GO:0003334) | 2.14694254 |
| 171 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.13859085 |
| 172 | regulation of macrophage chemotaxis (GO:0010758) | 2.13351247 |
| 173 | negative regulation of lipid storage (GO:0010888) | 2.13110686 |
| 174 | germinal center formation (GO:0002467) | 2.12896905 |
| 175 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.12371864 |
| 176 | phospholipid translocation (GO:0045332) | 2.11974992 |
| 177 | lipid translocation (GO:0034204) | 2.11974992 |
| 178 | tryptophan catabolic process (GO:0006569) | 2.11839442 |
| 179 | indole-containing compound catabolic process (GO:0042436) | 2.11839442 |
| 180 | indolalkylamine catabolic process (GO:0046218) | 2.11839442 |
| 181 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.10041936 |
| 182 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.09141519 |
| 183 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.06991082 |
| 184 | retinal metabolic process (GO:0042574) | 2.06804164 |
| 185 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.05772123 |
| 186 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.05617324 |
| 187 | tolerance induction (GO:0002507) | 2.05265015 |
| 188 | cellular response to interferon-gamma (GO:0071346) | 2.05099711 |
| 189 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.05076869 |
| 190 | megakaryocyte development (GO:0035855) | 2.03896597 |
| 191 | response to muramyl dipeptide (GO:0032495) | 2.03046233 |
| 192 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.02998659 |
| 193 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.02933970 |
| 194 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.01990071 |
| 195 | positive regulation of type 2 immune response (GO:0002830) | 2.01283556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.40554629 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.63914499 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.79228141 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.66706150 |
| 5 | GATA1_22025678_ChIP-Seq_K562_Human | 2.59019530 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.56798944 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.56457275 |
| 8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.48490944 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.40780087 |
| 10 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.34500311 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.33277053 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.29804984 |
| 13 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.28795517 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.24804032 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.23426387 |
| 16 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.23137527 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.18734045 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.17355447 |
| 19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.16962733 |
| 20 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.13018870 |
| 21 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.12226102 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.10608735 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.08191757 |
| 24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.08191757 |
| 25 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.08075770 |
| 26 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.01203379 |
| 27 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.98635253 |
| 28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.96009049 |
| 29 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.95374620 |
| 30 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.90997956 |
| 31 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.86260953 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.85541652 |
| 33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.85298171 |
| 34 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.83872210 |
| 35 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.83870734 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.82743536 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.80873312 |
| 38 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.78245563 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.76593689 |
| 40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75632849 |
| 41 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.73628965 |
| 42 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.66508032 |
| 43 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.65642462 |
| 44 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.64380327 |
| 45 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.63683391 |
| 46 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.61676335 |
| 47 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.59969143 |
| 48 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.58345163 |
| 49 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.56961771 |
| 50 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.56535386 |
| 51 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55478809 |
| 52 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.53817312 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.53282371 |
| 54 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.53043355 |
| 55 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51832078 |
| 56 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.51208622 |
| 57 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.47414684 |
| 58 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.47210257 |
| 59 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.46532733 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45878474 |
| 61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44785563 |
| 62 | AR_25329375_ChIP-Seq_VCAP_Human | 1.44159919 |
| 63 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.43474694 |
| 64 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.43373898 |
| 65 | TP53_16413492_ChIP-PET_HCT116_Human | 1.43031519 |
| 66 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.42081111 |
| 67 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36245647 |
| 68 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.35911171 |
| 69 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.35911171 |
| 70 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.35608786 |
| 71 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35364796 |
| 72 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35104861 |
| 73 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.35097330 |
| 74 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.34813444 |
| 75 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32487799 |
| 76 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.32077173 |
| 77 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.30940364 |
| 78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30780203 |
| 79 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30346958 |
| 80 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.29963706 |
| 81 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28996356 |
| 82 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28851428 |
| 83 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.27839329 |
| 84 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27437812 |
| 85 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.27053662 |
| 86 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.25611081 |
| 87 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.24352851 |
| 88 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.23976819 |
| 89 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.23777072 |
| 90 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.21789094 |
| 91 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.21371993 |
| 92 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.21285240 |
| 93 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20336015 |
| 94 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19977539 |
| 95 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.19786128 |
| 96 | MYB_26560356_Chip-Seq_TH2_Human | 1.19722121 |
| 97 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19661665 |
| 98 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.19229509 |
| 99 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.19217948 |
| 100 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.19007727 |
| 101 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18783941 |
| 102 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.18516121 |
| 103 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.18109880 |
| 104 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17957054 |
| 105 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17783790 |
| 106 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.17498775 |
| 107 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16971354 |
| 108 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.16638548 |
| 109 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.16524253 |
| 110 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.16247716 |
| 111 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15832168 |
| 112 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.15822410 |
| 113 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.13857669 |
| 114 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.13801207 |
| 115 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.13699461 |
| 116 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.11075149 |
| 117 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11062129 |
| 118 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09757855 |
| 119 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09140031 |
| 120 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08055786 |
| 121 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07888765 |
| 122 | TCF4_23295773_ChIP-Seq_U87_Human | 1.07628449 |
| 123 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07492355 |
| 124 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.07071127 |
| 125 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.06824967 |
| 126 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05982987 |
| 127 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05948833 |
| 128 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.05295184 |
| 129 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05090614 |
| 130 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.05055603 |
| 131 | KDM2B_26808549_Chip-Seq_REH_Human | 1.04576311 |
| 132 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.03215495 |
| 133 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02430885 |
| 134 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.02337677 |
| 135 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.01758425 |
| 136 | VDR_22108803_ChIP-Seq_LS180_Human | 1.01711138 |
| 137 | JUN_21703547_ChIP-Seq_K562_Human | 1.01478872 |
| 138 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01187374 |
| 139 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.01092731 |
| 140 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00999520 |
| 141 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00085187 |
| 142 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.00056998 |
| 143 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.99217095 |
| 144 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98996286 |
| 145 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.98446218 |
| 146 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.97982705 |
| 147 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.97226741 |
| 148 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97134663 |
| 149 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97046674 |
| 150 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.97035068 |
| 151 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.96541173 |
| 152 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96324111 |
| 153 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96212105 |
| 154 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95953268 |
| 155 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.95074313 |
| 156 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.94749420 |
| 157 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.94701898 |
| 158 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.94497092 |
| 159 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.94448285 |
| 160 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.94417733 |
| 161 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.93941398 |
| 162 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93824432 |
| 163 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93223593 |
| 164 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93223593 |
| 165 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93154818 |
| 166 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92882635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.34936751 |
| 2 | MP0003880_abnormal_central_pattern | 3.96642797 |
| 3 | MP0002735_abnormal_chemical_nociception | 3.75233270 |
| 4 | MP0001968_abnormal_touch/_nociception | 3.56911764 |
| 5 | MP0003300_gastrointestinal_ulcer | 3.48050562 |
| 6 | MP0004270_analgesia | 3.46565437 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 3.20118834 |
| 8 | MP0002736_abnormal_nociception_after | 2.90681351 |
| 9 | MP0009745_abnormal_behavioral_response | 2.86052835 |
| 10 | MP0002734_abnormal_mechanical_nocicepti | 2.85517538 |
| 11 | MP0010386_abnormal_urinary_bladder | 2.67524954 |
| 12 | MP0009046_muscle_twitch | 2.61324798 |
| 13 | MP0002064_seizures | 2.56031161 |
| 14 | MP0003303_peritoneal_inflammation | 2.51050792 |
| 15 | MP0002063_abnormal_learning/memory/cond | 2.49750140 |
| 16 | MP0002733_abnormal_thermal_nociception | 2.39059038 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.37790091 |
| 18 | MP0003950_abnormal_plasma_membrane | 2.37627053 |
| 19 | MP0001970_abnormal_pain_threshold | 2.35541564 |
| 20 | MP0002572_abnormal_emotion/affect_behav | 2.32249628 |
| 21 | MP0002272_abnormal_nervous_system | 2.31324622 |
| 22 | MP0001501_abnormal_sleep_pattern | 2.31162385 |
| 23 | MP0001986_abnormal_taste_sensitivity | 2.25953852 |
| 24 | MP0005423_abnormal_somatic_nervous | 2.18466877 |
| 25 | MP0001873_stomach_inflammation | 2.14605363 |
| 26 | MP0005670_abnormal_white_adipose | 2.14380544 |
| 27 | MP0003436_decreased_susceptibility_to | 2.11424169 |
| 28 | MP0001440_abnormal_grooming_behavior | 2.05376204 |
| 29 | MP0002822_catalepsy | 1.93587552 |
| 30 | MP0002067_abnormal_sensory_capabilities | 1.93193717 |
| 31 | MP0008004_abnormal_stomach_pH | 1.88291393 |
| 32 | MP0004858_abnormal_nervous_system | 1.85303876 |
| 33 | MP0001800_abnormal_humoral_immune | 1.76004888 |
| 34 | MP0003195_calcinosis | 1.72654447 |
| 35 | MP0004510_myositis | 1.71391598 |
| 36 | MP0010352_gastrointestinal_tract_polyps | 1.70906666 |
| 37 | MP0004043_abnormal_pH_regulation | 1.70024008 |
| 38 | MP0002184_abnormal_innervation | 1.66056425 |
| 39 | MP0001188_hyperpigmentation | 1.66019586 |
| 40 | MP0003252_abnormal_bile_duct | 1.64813551 |
| 41 | MP0001486_abnormal_startle_reflex | 1.64722056 |
| 42 | MP0004782_abnormal_surfactant_physiolog | 1.62588564 |
| 43 | MP0004924_abnormal_behavior | 1.61434815 |
| 44 | MP0005386_behavior/neurological_phenoty | 1.61434815 |
| 45 | MP0005166_decreased_susceptibility_to | 1.60908473 |
| 46 | MP0008875_abnormal_xenobiotic_pharmacok | 1.59319858 |
| 47 | MP0009764_decreased_sensitivity_to | 1.57997473 |
| 48 | MP0001348_abnormal_lacrimal_gland | 1.57603634 |
| 49 | MP0002163_abnormal_gland_morphology | 1.56334703 |
| 50 | MP0000569_abnormal_digit_pigmentation | 1.54135406 |
| 51 | MP0004947_skin_inflammation | 1.54020549 |
| 52 | MP0002452_abnormal_antigen_presenting | 1.52062774 |
| 53 | MP0010155_abnormal_intestine_physiology | 1.51412661 |
| 54 | MP0008569_lethality_at_weaning | 1.50108554 |
| 55 | MP0005025_abnormal_response_to | 1.44760316 |
| 56 | MP0009780_abnormal_chondrocyte_physiolo | 1.43014664 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.41992246 |
| 58 | MP0001905_abnormal_dopamine_level | 1.41734684 |
| 59 | MP0003763_abnormal_thymus_physiology | 1.41196724 |
| 60 | MP0009840_abnormal_foam_cell | 1.40062382 |
| 61 | MP0003787_abnormal_imprinting | 1.39523211 |
| 62 | MP0004811_abnormal_neuron_physiology | 1.37613830 |
| 63 | MP0001835_abnormal_antigen_presentation | 1.37394079 |
| 64 | MP0002557_abnormal_social/conspecific_i | 1.36381792 |
| 65 | MP0008057_abnormal_DNA_replication | 1.35095367 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 1.34847163 |
| 67 | MP0003879_abnormal_hair_cell | 1.32715631 |
| 68 | MP0005083_abnormal_biliary_tract | 1.31088138 |
| 69 | MP0001851_eye_inflammation | 1.29979409 |
| 70 | MP0005310_abnormal_salivary_gland | 1.29709973 |
| 71 | MP0005379_endocrine/exocrine_gland_phen | 1.29385586 |
| 72 | MP0001533_abnormal_skeleton_physiology | 1.28440834 |
| 73 | MP0001845_abnormal_inflammatory_respons | 1.28240396 |
| 74 | MP0001984_abnormal_olfaction | 1.28168074 |
| 75 | MP0002148_abnormal_hypersensitivity_rea | 1.26810598 |
| 76 | MP0005023_abnormal_wound_healing | 1.26576567 |
| 77 | MP0003183_abnormal_peptide_metabolism | 1.26351494 |
| 78 | MP0009785_altered_susceptibility_to | 1.26005008 |
| 79 | MP0005671_abnormal_response_to | 1.25527255 |
| 80 | MP0000613_abnormal_salivary_gland | 1.25444187 |
| 81 | MP0002405_respiratory_system_inflammati | 1.24219247 |
| 82 | MP0005365_abnormal_bile_salt | 1.19239731 |
| 83 | MP0001666_abnormal_nutrient_absorption | 1.18653559 |
| 84 | MP0002909_abnormal_adrenal_gland | 1.16622202 |
| 85 | MP0001529_abnormal_vocalization | 1.16232568 |
| 86 | MP0001502_abnormal_circadian_rhythm | 1.15221836 |
| 87 | MP0005164_abnormal_response_to | 1.13164899 |
| 88 | MP0003633_abnormal_nervous_system | 1.13161106 |
| 89 | MP0000778_abnormal_nervous_system | 1.12885530 |
| 90 | MP0005645_abnormal_hypothalamus_physiol | 1.12415025 |
| 91 | MP0000955_abnormal_spinal_cord | 1.10929793 |
| 92 | MP0002139_abnormal_hepatobiliary_system | 1.09377824 |
| 93 | MP0005535_abnormal_body_temperature | 1.07967961 |
| 94 | MP0000015_abnormal_ear_pigmentation | 1.07563384 |
| 95 | MP0001853_heart_inflammation | 1.06743369 |
| 96 | MP0002066_abnormal_motor_capabilities/c | 1.03062481 |
| 97 | MP0002638_abnormal_pupillary_reflex | 1.02534917 |
| 98 | MP0002882_abnormal_neuron_morphology | 1.01330348 |
| 99 | MP0005000_abnormal_immune_tolerance | 1.01017092 |
| 100 | MP0008872_abnormal_physiological_respon | 1.00451340 |
| 101 | MP0003724_increased_susceptibility_to | 1.00427534 |
| 102 | MP0003868_abnormal_feces_composition | 1.00211577 |
| 103 | MP0001545_abnormal_hematopoietic_system | 0.99847690 |
| 104 | MP0005397_hematopoietic_system_phenotyp | 0.99847690 |
| 105 | MP0005220_abnormal_exocrine_pancreas | 0.98626028 |
| 106 | MP0004147_increased_porphyrin_level | 0.98254300 |
| 107 | MP0005646_abnormal_pituitary_gland | 0.96552699 |
| 108 | MP0004742_abnormal_vestibular_system | 0.95152447 |
| 109 | MP0002132_abnormal_respiratory_system | 0.94492754 |
| 110 | MP0000716_abnormal_immune_system | 0.92744484 |
| 111 | MP0001790_abnormal_immune_system | 0.92417507 |
| 112 | MP0005387_immune_system_phenotype | 0.92417507 |
| 113 | MP0004142_abnormal_muscle_tone | 0.92370784 |
| 114 | MP0005464_abnormal_platelet_physiology | 0.92121167 |
| 115 | MP0003828_pulmonary_edema | 0.91931337 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.91151818 |
| 117 | MP0003122_maternal_imprinting | 0.91078791 |
| 118 | MP0008961_abnormal_basal_metabolism | 0.90147223 |
| 119 | MP0003631_nervous_system_phenotype | 0.90033834 |
| 120 | MP0002168_other_aberrant_phenotype | 0.89624854 |
| 121 | MP0002751_abnormal_autonomic_nervous | 0.89222559 |
| 122 | MP0008874_decreased_physiological_sensi | 0.88419245 |
| 123 | MP0008469_abnormal_protein_level | 0.88205334 |
| 124 | MP0006082_CNS_inflammation | 0.88020605 |
| 125 | MP0009379_abnormal_foot_pigmentation | 0.87998035 |
| 126 | MP0002398_abnormal_bone_marrow | 0.86754401 |
| 127 | MP0001756_abnormal_urination | 0.86126925 |
| 128 | MP0003075_altered_response_to | 0.85246564 |
| 129 | MP0002928_abnormal_bile_duct | 0.84572049 |
| 130 | MP0008873_increased_physiological_sensi | 0.82751383 |
| 131 | MP0003045_fibrosis | 0.81832490 |
| 132 | MP0009643_abnormal_urine_homeostasis | 0.81753272 |
| 133 | MP0002998_abnormal_bone_remodeling | 0.81739302 |
| 134 | MP0005409_darkened_coat_color | 0.81682723 |
| 135 | MP0002136_abnormal_kidney_physiology | 0.81086846 |
| 136 | MP0003329_amyloid_beta_deposits | 0.81034744 |
| 137 | MP0000343_altered_response_to | 0.80560009 |
| 138 | MP0000920_abnormal_myelination | 0.79523149 |
| 139 | MP0005410_abnormal_fertilization | 0.78891110 |
| 140 | MP0002876_abnormal_thyroid_physiology | 0.78821729 |
| 141 | MP0003091_abnormal_cell_migration | 0.77433313 |
| 142 | MP0005165_increased_susceptibility_to | 0.76803104 |
| 143 | MP0001663_abnormal_digestive_system | 0.75765646 |
| 144 | MP0003448_altered_tumor_morphology | 0.73475977 |
| 145 | MP0003866_abnormal_defecation | 0.73359520 |
| 146 | MP0005167_abnormal_blood-brain_barrier | 0.71636480 |
| 147 | MP0002009_preneoplasia | 0.71070145 |
| 148 | MP0002723_abnormal_immune_serum | 0.69809655 |
| 149 | MP0002229_neurodegeneration | 0.68249475 |
| 150 | MP0005171_absent_coat_pigmentation | 0.68192560 |
| 151 | MP0000685_abnormal_immune_system | 0.66328367 |
| 152 | MP0002006_tumorigenesis | 0.65446805 |
| 153 | MP0000538_abnormal_urinary_bladder | 0.65158343 |
| 154 | MP0005174_abnormal_tail_pigmentation | 0.64984547 |
| 155 | MP0001765_abnormal_ion_homeostasis | 0.63651236 |
| 156 | MP0002138_abnormal_hepatobiliary_system | 0.62194033 |
| 157 | MP0001819_abnormal_immune_cell | 0.61796639 |
| 158 | MP0002277_abnormal_respiratory_mucosa | 0.60765834 |
| 159 | MP0002166_altered_tumor_susceptibility | 0.60300895 |
| 160 | MP0002069_abnormal_eating/drinking_beha | 0.60265442 |
| 161 | MP0004484_altered_response_of | 0.60200004 |
| 162 | MP0002420_abnormal_adaptive_immunity | 0.60112559 |
| 163 | MP0004883_abnormal_blood_vessel | 0.58178176 |
| 164 | MP0004885_abnormal_endolymph | 0.57953997 |
| 165 | MP0002419_abnormal_innate_immunity | 0.57928418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.22400058 |
| 2 | Myokymia (HP:0002411) | 5.59341221 |
| 3 | Visual hallucinations (HP:0002367) | 4.79284902 |
| 4 | Atonic seizures (HP:0010819) | 4.73315621 |
| 5 | Febrile seizures (HP:0002373) | 4.71896428 |
| 6 | Focal seizures (HP:0007359) | 4.69147846 |
| 7 | Stomach cancer (HP:0012126) | 4.46965552 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.21933702 |
| 9 | Epileptic encephalopathy (HP:0200134) | 4.20595053 |
| 10 | Hypothermia (HP:0002045) | 3.89206489 |
| 11 | Absence seizures (HP:0002121) | 3.78283568 |
| 12 | Alopecia of scalp (HP:0002293) | 3.55231576 |
| 13 | Alveolar cell carcinoma (HP:0006519) | 3.55214222 |
| 14 | Dialeptic seizures (HP:0011146) | 3.53137479 |
| 15 | Neoplasm of the tracheobronchial system (HP:0100552) | 3.35593225 |
| 16 | Generalized tonic-clonic seizures (HP:0002069) | 3.25070158 |
| 17 | Action tremor (HP:0002345) | 3.20587740 |
| 18 | Hypokalemic alkalosis (HP:0001949) | 3.15263557 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.14818560 |
| 20 | Optic neuritis (HP:0100653) | 3.14818560 |
| 21 | Stomatitis (HP:0010280) | 3.12591658 |
| 22 | Papilledema (HP:0001085) | 3.07363528 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.03288743 |
| 24 | Abnormality of chloride homeostasis (HP:0011422) | 3.00910603 |
| 25 | Steatorrhea (HP:0002570) | 3.00127397 |
| 26 | Exocrine pancreatic insufficiency (HP:0001738) | 2.99943510 |
| 27 | Amblyopia (HP:0000646) | 2.97561363 |
| 28 | Neuroendocrine neoplasm (HP:0100634) | 2.94957977 |
| 29 | Peripheral hypomyelination (HP:0007182) | 2.88940392 |
| 30 | Abnormal hair whorl (HP:0010721) | 2.88684451 |
| 31 | Follicular hyperkeratosis (HP:0007502) | 2.85783486 |
| 32 | Pheochromocytoma (HP:0002666) | 2.84623013 |
| 33 | Supranuclear gaze palsy (HP:0000605) | 2.82513757 |
| 34 | Progressive inability to walk (HP:0002505) | 2.80197842 |
| 35 | Autoimmune hemolytic anemia (HP:0001890) | 2.72938251 |
| 36 | Truncal ataxia (HP:0002078) | 2.70089634 |
| 37 | Gaze-evoked nystagmus (HP:0000640) | 2.63600091 |
| 38 | Interstitial pulmonary disease (HP:0006530) | 2.62716914 |
| 39 | Metabolic alkalosis (HP:0200114) | 2.62297249 |
| 40 | Limb dystonia (HP:0002451) | 2.61550186 |
| 41 | Anxiety (HP:0000739) | 2.59714819 |
| 42 | Facial shape deformation (HP:0011334) | 2.59037899 |
| 43 | Potter facies (HP:0002009) | 2.59037899 |
| 44 | Orchitis (HP:0100796) | 2.54040095 |
| 45 | Abnormality of the prostate (HP:0008775) | 2.53388602 |
| 46 | Abnormality of dental color (HP:0011073) | 2.50482711 |
| 47 | Widely spaced teeth (HP:0000687) | 2.50025298 |
| 48 | Prostate neoplasm (HP:0100787) | 2.47104373 |
| 49 | Depression (HP:0000716) | 2.44346917 |
| 50 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.42510237 |
| 51 | Abnormality of the nasal septum (HP:0000419) | 2.42406368 |
| 52 | Hyperventilation (HP:0002883) | 2.41078034 |
| 53 | Scanning speech (HP:0002168) | 2.40997556 |
| 54 | Fat malabsorption (HP:0002630) | 2.39161319 |
| 55 | Broad-based gait (HP:0002136) | 2.38642772 |
| 56 | Ulnar claw (HP:0001178) | 2.35494551 |
| 57 | Recurrent bronchitis (HP:0002837) | 2.33535688 |
| 58 | Increased IgM level (HP:0003496) | 2.31185280 |
| 59 | Dysmetric saccades (HP:0000641) | 2.31121474 |
| 60 | Abnormal eating behavior (HP:0100738) | 2.30055720 |
| 61 | Slow saccadic eye movements (HP:0000514) | 2.28465370 |
| 62 | Myositis (HP:0100614) | 2.27706367 |
| 63 | Joint swelling (HP:0001386) | 2.25487953 |
| 64 | Abnormality of the renal cortex (HP:0011035) | 2.25420542 |
| 65 | Hypoproteinemia (HP:0003075) | 2.23916549 |
| 66 | Erythema (HP:0010783) | 2.23252526 |
| 67 | Hyperaldosteronism (HP:0000859) | 2.22888675 |
| 68 | Autoimmune thrombocytopenia (HP:0001973) | 2.20121717 |
| 69 | Failure to thrive in infancy (HP:0001531) | 2.20084833 |
| 70 | Abnormality of binocular vision (HP:0011514) | 2.19979666 |
| 71 | Diplopia (HP:0000651) | 2.19979666 |
| 72 | Agitation (HP:0000713) | 2.19764406 |
| 73 | Gait imbalance (HP:0002141) | 2.18881660 |
| 74 | Impaired smooth pursuit (HP:0007772) | 2.17491072 |
| 75 | Anhidrosis (HP:0000970) | 2.17125811 |
| 76 | Vascular calcification (HP:0004934) | 2.16921202 |
| 77 | Poor eye contact (HP:0000817) | 2.14556556 |
| 78 | Chronic diarrhea (HP:0002028) | 2.11287890 |
| 79 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.11287301 |
| 80 | Increased CSF protein (HP:0002922) | 2.11274803 |
| 81 | Decreased circulating renin level (HP:0003351) | 2.10895568 |
| 82 | Abnormality of B cell number (HP:0010975) | 2.10885741 |
| 83 | Glomerulonephritis (HP:0000099) | 2.10769002 |
| 84 | Chronic otitis media (HP:0000389) | 2.10751728 |
| 85 | Abnormality of the right ventricle (HP:0001707) | 2.10446882 |
| 86 | Menstrual irregularities (HP:0000858) | 2.10101566 |
| 87 | Genetic anticipation (HP:0003743) | 2.09678024 |
| 88 | Hyperactive renin-angiotensin system (HP:0000841) | 2.09462816 |
| 89 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.08218536 |
| 90 | Heterochromia iridis (HP:0001100) | 2.07465603 |
| 91 | Dysautonomia (HP:0002459) | 2.07124595 |
| 92 | Cerebral hemorrhage (HP:0001342) | 2.06115564 |
| 93 | Dysmetria (HP:0001310) | 2.05975638 |
| 94 | Hypercortisolism (HP:0001578) | 2.05851981 |
| 95 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.05788505 |
| 96 | Psychosis (HP:0000709) | 2.05661556 |
| 97 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.02731978 |
| 98 | Abnormality of the corticospinal tract (HP:0002492) | 2.01745897 |
| 99 | Hypoventilation (HP:0002791) | 2.00966798 |
| 100 | Protruding tongue (HP:0010808) | 2.00332449 |
| 101 | Azoospermia (HP:0000027) | 2.00245209 |
| 102 | Fair hair (HP:0002286) | 1.99847495 |
| 103 | Abnormality of T cell number (HP:0011839) | 1.99743563 |
| 104 | Nephritis (HP:0000123) | 1.99504823 |
| 105 | Abnormality of the periventricular white matter (HP:0002518) | 1.98338140 |
| 106 | Blue irides (HP:0000635) | 1.97466671 |
| 107 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.97436472 |
| 108 | Ankle clonus (HP:0011448) | 1.95566493 |
| 109 | Inability to walk (HP:0002540) | 1.95499100 |
| 110 | Cardiovascular calcification (HP:0011915) | 1.95362894 |
| 111 | Absent/shortened dynein arms (HP:0200106) | 1.95139132 |
| 112 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.95139132 |
| 113 | Genital tract atresia (HP:0001827) | 1.94599912 |
| 114 | Thyroid carcinoma (HP:0002890) | 1.94277470 |
| 115 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.94096574 |
| 116 | Metaphyseal dysplasia (HP:0100255) | 1.93975185 |
| 117 | Inappropriate behavior (HP:0000719) | 1.93722145 |
| 118 | Systemic lupus erythematosus (HP:0002725) | 1.93500103 |
| 119 | Abnormality of renin-angiotensin system (HP:0000847) | 1.93397621 |
| 120 | Alkalosis (HP:0001948) | 1.93123100 |
| 121 | Abnormality of male internal genitalia (HP:0000022) | 1.92991892 |
| 122 | Mutism (HP:0002300) | 1.92123685 |
| 123 | Cone-rod dystrophy (HP:0000548) | 1.91860456 |
| 124 | Bradykinesia (HP:0002067) | 1.90976669 |
| 125 | Drooling (HP:0002307) | 1.90917362 |
| 126 | Excessive salivation (HP:0003781) | 1.90917362 |
| 127 | Congenital primary aphakia (HP:0007707) | 1.90632369 |
| 128 | Hemiparesis (HP:0001269) | 1.89227685 |
| 129 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.88665429 |
| 130 | Vaginal atresia (HP:0000148) | 1.88642290 |
| 131 | Ileus (HP:0002595) | 1.87911948 |
| 132 | Abnormality of T cell physiology (HP:0011840) | 1.87677463 |
| 133 | Spinal canal stenosis (HP:0003416) | 1.87563303 |
| 134 | Medial flaring of the eyebrow (HP:0010747) | 1.87149958 |
| 135 | Keratoconjunctivitis sicca (HP:0001097) | 1.86680733 |
| 136 | Glucose intolerance (HP:0000833) | 1.85940406 |
| 137 | Petechiae (HP:0000967) | 1.85627617 |
| 138 | Absent speech (HP:0001344) | 1.85382723 |
| 139 | Stereotypic behavior (HP:0000733) | 1.84892458 |
| 140 | Polyphagia (HP:0002591) | 1.84494540 |
| 141 | Generalized hypopigmentation of hair (HP:0011358) | 1.84431543 |
| 142 | Vasculitis (HP:0002633) | 1.84161985 |
| 143 | Myotonia (HP:0002486) | 1.83081586 |
| 144 | Conical tooth (HP:0000698) | 1.82526994 |
| 145 | Nephrogenic diabetes insipidus (HP:0009806) | 1.82384964 |
| 146 | Increased circulating renin level (HP:0000848) | 1.81995620 |
| 147 | Dysdiadochokinesis (HP:0002075) | 1.80985264 |
| 148 | Abnormality of salivation (HP:0100755) | 1.80136264 |
| 149 | Pulmonary fibrosis (HP:0002206) | 1.79504924 |
| 150 | Pancreatitis (HP:0001733) | 1.79399701 |
| 151 | Abnormality of saccadic eye movements (HP:0000570) | 1.78545978 |
| 152 | Keratitis (HP:0000491) | 1.78229680 |
| 153 | Tubulointerstitial fibrosis (HP:0005576) | 1.78089984 |
| 154 | Sparse eyelashes (HP:0000653) | 1.77543378 |
| 155 | Abnormal biliary tract morphology (HP:0012440) | 1.77203930 |
| 156 | Arterial tortuosity (HP:0005116) | 1.77197490 |
| 157 | Epileptiform EEG discharges (HP:0011182) | 1.75610979 |
| 158 | Abnormality of the pleura (HP:0002103) | 1.75512925 |
| 159 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.75447401 |
| 160 | Abnormal social behavior (HP:0012433) | 1.74651352 |
| 161 | Impaired social interactions (HP:0000735) | 1.74651352 |
| 162 | Renal salt wasting (HP:0000127) | 1.74535021 |
| 163 | Orthostatic hypotension (HP:0001278) | 1.73868869 |
| 164 | Subacute progressive viral hepatitis (HP:0006572) | 1.73314807 |
| 165 | Lip pit (HP:0100267) | 1.73110543 |
| 166 | Prolonged bleeding time (HP:0003010) | 1.72858154 |
| 167 | Pulmonary infiltrates (HP:0002113) | 1.71862677 |
| 168 | Akinesia (HP:0002304) | 1.71802945 |
| 169 | Fetal akinesia sequence (HP:0001989) | 1.71619005 |
| 170 | Hypomagnesemia (HP:0002917) | 1.69679467 |
| 171 | Keratoconjunctivitis (HP:0001096) | 1.69067500 |
| 172 | Termporal pattern (HP:0011008) | 1.68026398 |
| 173 | Insidious onset (HP:0003587) | 1.68026398 |
| 174 | Specific learning disability (HP:0001328) | 1.64825393 |
| 175 | Recurrent abscess formation (HP:0002722) | 1.64389464 |
| 176 | Urinary urgency (HP:0000012) | 1.63785785 |
| 177 | Nuclear cataract (HP:0100018) | 1.62922926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 4.43494552 |
| 2 | NTRK3 | 4.03790956 |
| 3 | MAP3K12 | 3.86989631 |
| 4 | RIPK4 | 3.52719667 |
| 5 | TAOK3 | 3.02964510 |
| 6 | STK39 | 2.73684579 |
| 7 | MINK1 | 2.53849991 |
| 8 | MAP2K7 | 2.43382538 |
| 9 | EPHA2 | 2.36689562 |
| 10 | CASK | 2.28012899 |
| 11 | GRK5 | 2.26495930 |
| 12 | MAP3K4 | 2.21245159 |
| 13 | MAP3K9 | 2.16277391 |
| 14 | NTRK1 | 2.14997676 |
| 15 | GRK1 | 2.09305651 |
| 16 | EIF2AK3 | 2.06725984 |
| 17 | BMPR2 | 2.03220084 |
| 18 | KSR2 | 2.00225135 |
| 19 | MAP3K14 | 1.96194305 |
| 20 | MAP3K2 | 1.91178474 |
| 21 | BRSK2 | 1.81987735 |
| 22 | EPHA4 | 1.78669861 |
| 23 | SIK3 | 1.72832828 |
| 24 | PLK2 | 1.69323725 |
| 25 | MARK1 | 1.67906559 |
| 26 | DAPK2 | 1.66962889 |
| 27 | MAPK13 | 1.60434300 |
| 28 | DAPK1 | 1.60406196 |
| 29 | SIK2 | 1.52920265 |
| 30 | PTK2B | 1.50758463 |
| 31 | BMPR1B | 1.49703376 |
| 32 | MAP2K4 | 1.49448884 |
| 33 | ADRBK2 | 1.48327474 |
| 34 | STK38L | 1.43004554 |
| 35 | CAMKK2 | 1.40272810 |
| 36 | FES | 1.37474837 |
| 37 | PIK3CA | 1.35487864 |
| 38 | TNIK | 1.31500911 |
| 39 | RET | 1.31352096 |
| 40 | ARAF | 1.25744957 |
| 41 | STK3 | 1.24965941 |
| 42 | TXK | 1.21564557 |
| 43 | CDK19 | 1.20626832 |
| 44 | MAP3K13 | 1.19687106 |
| 45 | ITK | 1.18739799 |
| 46 | SGK2 | 1.17657289 |
| 47 | CHUK | 1.15608731 |
| 48 | STK38 | 1.15268768 |
| 49 | RIPK1 | 1.15038670 |
| 50 | TGFBR2 | 1.14077631 |
| 51 | CDK5 | 1.13390927 |
| 52 | MAP3K3 | 1.11013141 |
| 53 | NTRK2 | 1.09344633 |
| 54 | MATK | 1.07945623 |
| 55 | TYK2 | 1.06805872 |
| 56 | KIT | 1.06227319 |
| 57 | MST4 | 1.04754731 |
| 58 | SYK | 1.04061967 |
| 59 | BTK | 1.01915233 |
| 60 | MST1R | 1.01576022 |
| 61 | WNK1 | 0.99899152 |
| 62 | TRPM7 | 0.99540846 |
| 63 | FRK | 0.99301095 |
| 64 | TNK2 | 0.98791265 |
| 65 | PNCK | 0.97857914 |
| 66 | IRAK1 | 0.97193637 |
| 67 | PRKG2 | 0.96242756 |
| 68 | SGK223 | 0.92873322 |
| 69 | SGK494 | 0.92873322 |
| 70 | IKBKE | 0.92030028 |
| 71 | OXSR1 | 0.91819363 |
| 72 | PRKCE | 0.87775628 |
| 73 | MAP3K1 | 0.86167516 |
| 74 | PAK6 | 0.85435098 |
| 75 | GRK7 | 0.82705774 |
| 76 | EIF2AK2 | 0.82534664 |
| 77 | UHMK1 | 0.82154330 |
| 78 | PDK2 | 0.81206739 |
| 79 | GRK6 | 0.80597840 |
| 80 | MET | 0.80590235 |
| 81 | CAMKK1 | 0.79593542 |
| 82 | JAK1 | 0.79161021 |
| 83 | MAPKAPK3 | 0.78677823 |
| 84 | JAK3 | 0.77533662 |
| 85 | TBK1 | 0.77087880 |
| 86 | WNK3 | 0.76673716 |
| 87 | STK10 | 0.76582413 |
| 88 | SGK3 | 0.73484877 |
| 89 | CAMK2A | 0.72127472 |
| 90 | WNK4 | 0.70426938 |
| 91 | MAPKAPK5 | 0.67716185 |
| 92 | FGFR3 | 0.67233704 |
| 93 | ADRBK1 | 0.66961143 |
| 94 | PRKCG | 0.66599791 |
| 95 | PRPF4B | 0.66102114 |
| 96 | RPS6KA2 | 0.63264598 |
| 97 | ZAP70 | 0.61389895 |
| 98 | IKBKB | 0.61234606 |
| 99 | NUAK1 | 0.60700206 |
| 100 | NEK6 | 0.58855221 |
| 101 | YES1 | 0.58524017 |
| 102 | KSR1 | 0.58318331 |
| 103 | PINK1 | 0.57686451 |
| 104 | ABL1 | 0.57185355 |
| 105 | NLK | 0.56675333 |
| 106 | MAPK7 | 0.56459301 |
| 107 | LIMK1 | 0.56021218 |
| 108 | AKT3 | 0.55615907 |
| 109 | TRIM28 | 0.55249056 |
| 110 | EPHA3 | 0.55028533 |
| 111 | INSRR | 0.54574246 |
| 112 | CDK8 | 0.53956004 |
| 113 | HIPK2 | 0.52918649 |
| 114 | HCK | 0.52497257 |
| 115 | SGK1 | 0.52376469 |
| 116 | FGR | 0.51940167 |
| 117 | MAPK11 | 0.51185393 |
| 118 | MAP4K1 | 0.51167522 |
| 119 | RAF1 | 0.51017294 |
| 120 | LATS1 | 0.49720219 |
| 121 | MAP2K1 | 0.48995975 |
| 122 | PAK3 | 0.48495865 |
| 123 | BCR | 0.48272214 |
| 124 | CAMK2B | 0.46809174 |
| 125 | CDK14 | 0.45396303 |
| 126 | MAP3K7 | 0.45187852 |
| 127 | PDK1 | 0.44141654 |
| 128 | PRKAA2 | 0.42672406 |
| 129 | CDK18 | 0.42176124 |
| 130 | MELK | 0.41660048 |
| 131 | ERBB3 | 0.41609169 |
| 132 | FER | 0.40989187 |
| 133 | PRKCH | 0.40722174 |
| 134 | BLK | 0.40611701 |
| 135 | MAP2K6 | 0.39672382 |
| 136 | IGF1R | 0.39613674 |
| 137 | MAP2K2 | 0.38989801 |
| 138 | PRKCQ | 0.38646524 |
| 139 | STK24 | 0.37800156 |
| 140 | CAMK1 | 0.37639671 |
| 141 | JAK2 | 0.36059705 |
| 142 | MAPK4 | 0.35896404 |
| 143 | MYLK | 0.34902347 |
| 144 | ERN1 | 0.33897962 |
| 145 | CDK15 | 0.33615024 |
| 146 | PRKCD | 0.33592797 |
| 147 | CAMK2D | 0.33342631 |
| 148 | TEC | 0.32239103 |
| 149 | FYN | 0.32008687 |
| 150 | LCK | 0.31728672 |
| 151 | STK11 | 0.30900912 |
| 152 | PRKD3 | 0.29349873 |
| 153 | SCYL2 | 0.29023741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.67145340 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.63288879 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.08910253 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.07340590 |
| 5 | Asthma_Homo sapiens_hsa05310 | 1.97987093 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.97780514 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 1.97027439 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 1.92331870 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 1.87057389 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 1.87041032 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.84378683 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.84011190 |
| 13 | Circadian rhythm_Homo sapiens_hsa04710 | 1.81096680 |
| 14 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.78428090 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.78248438 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.67238099 |
| 17 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.67183900 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.67131759 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.62881059 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.62173582 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.60548339 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.59885399 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.57384839 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.50484663 |
| 25 | Hepatitis C_Homo sapiens_hsa05160 | 1.46346905 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.43330360 |
| 27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.40059254 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.37185683 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.36983570 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.36676693 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.35284498 |
| 32 | Allograft rejection_Homo sapiens_hsa05330 | 1.32686107 |
| 33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.31584373 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.31443870 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.29394104 |
| 36 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.28814166 |
| 37 | Cocaine addiction_Homo sapiens_hsa05030 | 1.24350856 |
| 38 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.24053136 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19741487 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.18617711 |
| 41 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.18103698 |
| 42 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.17977837 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.16251966 |
| 44 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.13471737 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12360319 |
| 46 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.12295093 |
| 47 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.09162742 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.09092835 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.08247981 |
| 50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.06472280 |
| 51 | Mineral absorption_Homo sapiens_hsa04978 | 1.04172209 |
| 52 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.03464962 |
| 53 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.01165978 |
| 54 | Malaria_Homo sapiens_hsa05144 | 0.99751537 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98353905 |
| 56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.97986028 |
| 57 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.97475248 |
| 58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.97143310 |
| 59 | Legionellosis_Homo sapiens_hsa05134 | 0.97100908 |
| 60 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.96227272 |
| 61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94945374 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94804331 |
| 63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.93334790 |
| 64 | Glioma_Homo sapiens_hsa05214 | 0.92950931 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.92262063 |
| 66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.92155548 |
| 67 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.91710286 |
| 68 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.90799466 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.90287966 |
| 70 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90179040 |
| 71 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.89115989 |
| 72 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.88590038 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88509148 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87886499 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.87425761 |
| 76 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.84530339 |
| 77 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.84236067 |
| 78 | Leishmaniasis_Homo sapiens_hsa05140 | 0.84218435 |
| 79 | Salmonella infection_Homo sapiens_hsa05132 | 0.84119952 |
| 80 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.83799429 |
| 81 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.83788297 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83679421 |
| 83 | Gap junction_Homo sapiens_hsa04540 | 0.83676902 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.82088341 |
| 85 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.80750839 |
| 86 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79691322 |
| 87 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.79635537 |
| 88 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78823403 |
| 89 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78627480 |
| 90 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77757765 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77609858 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76995691 |
| 93 | Alzheimers disease_Homo sapiens_hsa05010 | 0.75308184 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.74607494 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.74393359 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.73491144 |
| 97 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.73100877 |
| 98 | Bile secretion_Homo sapiens_hsa04976 | 0.72253939 |
| 99 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71845467 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.71107680 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71047380 |
| 102 | Tuberculosis_Homo sapiens_hsa05152 | 0.70629844 |
| 103 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69465185 |
| 104 | Pertussis_Homo sapiens_hsa05133 | 0.69184516 |
| 105 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68892023 |
| 106 | Histidine metabolism_Homo sapiens_hsa00340 | 0.68174355 |
| 107 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66843904 |
| 108 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66228934 |
| 109 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.66133049 |
| 110 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.65896365 |
| 111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65626836 |
| 112 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65472292 |
| 113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65401104 |
| 114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64990662 |
| 115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64654842 |
| 116 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64625902 |
| 117 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.63575088 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62681551 |
| 119 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.62124993 |
| 120 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.61542463 |
| 121 | Axon guidance_Homo sapiens_hsa04360 | 0.61356796 |
| 122 | Platelet activation_Homo sapiens_hsa04611 | 0.61097141 |
| 123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60585923 |
| 124 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58789377 |
| 125 | Melanogenesis_Homo sapiens_hsa04916 | 0.58552548 |
| 126 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58009287 |
| 127 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57677533 |
| 128 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57409675 |
| 129 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57111228 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56805389 |
| 131 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56725268 |
| 132 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.56175773 |
| 133 | Measles_Homo sapiens_hsa05162 | 0.53374607 |
| 134 | Parkinsons disease_Homo sapiens_hsa05012 | 0.52847749 |
| 135 | Influenza A_Homo sapiens_hsa05164 | 0.52343332 |
| 136 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51350050 |
| 137 | Hepatitis B_Homo sapiens_hsa05161 | 0.50764857 |
| 138 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50185096 |
| 139 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47029581 |
| 140 | Amoebiasis_Homo sapiens_hsa05146 | 0.46829123 |
| 141 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.45543915 |
| 142 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44565656 |
| 143 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42996412 |

